XML 37 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

Equity Incentive Plans | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Equity Incentive Plans | Note 12 – Equity Incentive Plans Directors Remuneration During the year ended December 31, 2024 On December 17,2024, the Company issued an RSU grant of 3,058 shares of common stock under the 2021 Equity Incentive Plan to newly elected independent director. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors. The award was issued such that 50% of the RSUs vested upon grant and the remaining 50% vested on the one-year anniversary of the award. A total of 1,529 shares of the Company’s common stock were issued in settlement of the RSUs effective December 17, 2024, the date of the grant. On January 2, 2024, the Company issued an RSU grant of 3,788 shares of common stock under the 2021 Equity Incentive Plan to three of its four independent directors. Mr. Shipley declined to receive the RSUs which he was entitled to receive. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 11,364 shares of the Company’s common stock were issued in settlement of the RSUs. CEA Industries Inc. Notes to Consolidated Financial Statements December 31, 2024 (in US Dollars except share numbers) During the year ended December 31, 2023 On January 3, 2023, the Company issued an RSU grant of 2,480 shares of common stock under the 2021 Equity Incentive Plan to each of its four independent directors. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 17, 2022 and vested immediately on the grant date. A total of 10,200 shares of the Company’s common stock were issued in settlement of the RSUs. Subsequent Events As further discussed in Note 14 Subsequent Events below, on January 2, 2025, the Company issued an RSU grant of 3,079 shares of common stock under the 2021 Equity Incentive Plan to each of its three independent directors who served the entire year of 2024. The RSUs were granted as an equity retention award pursuant to the Company’s compensation plan for independent directors effective January 2, 2025 and vested immediately on the grant date. A total of 9,237 shares of the Company’s common stock were issued in settlement of the RSUs. Revised Compensation Plan for Directors On December 16, 2024, the Board of Directors revised the previously adopted compensation plan. This plan supersedes the plan adopted on January 17, 2022. The Plan is effective retroactively for the current independent directors and for independent directors elected or appointed after the Effective Date. At the time of initial election or appointment, each independent director will receive an equity retention award in the form of restricted stock units (“RSUs”). The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the trade date immediately prior to the date of grant. Vesting of the RSUs will be as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date. In addition, on the first business day of January each year, each independent director who was not initially appointed or elected in the previous year will receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying the RSUs to be determined based on the closing price of the Company’s common stock on the trade date immediately prior to the date of grant. These RSUs will be fully vested at date of grant. There is no additional compensation paid to members of any committee of the Board. Directors who are also executives of the Company, serving on the Board, do not receive compensation for their Board service. All the independent directors, Messrs. Shipley, Etten, Mariathasan, and Tarallo are subject to the Plan. Each independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan, including the exercise of any non-qualified stock options. 2017 Equity Incentive Plan Under the Company’s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the “2017 Equity Plan”), the Board of Directors (the “Board”) (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates 27,778 shares of the Company’s common stock (“Plan Shares”) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan. As of December 31, 2024, of the 27,778 shares authorized under the 2017 Equity Plan, 13,641 relate to restricted shares issued, 11,615 relate to outstanding non-qualified stock options and 2,522 shares remain available for future equity awards. CEA Industries Inc. Notes to Consolidated Financial Statements December 31, 2024 (in US Dollars except share numbers) 2021 Equity Incentive Plan On March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the “2021 Equity Plan”), which was approved by the stockholders on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to 55,556 shares of common stock. The 2021 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), non-qualified stock options, stock appreciation rights (“SARs”), restricted stock awards and restricted stock unit awards and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without having been exercised in full or (ii) is settled in cash (i.e., the holder of the award receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant to this Plan. Equity Incentive Plan Issuances During 2024
- | Issued 1,529 shares of common stock in settlement of restricted stock units issued to a newly elected independent director. The grant was for a total of 3,058 shares, 50% of which vested immediately and the remaining units will vest in one year.
- | Issued 11,364 shares of its common stock in settlement of restricted stock units issued to three of its independent directors under the 2021 Equity Incentive Plan, pursuant to the Director Compensation plan adopted on January 17, 2022.
- | 3,297 non-qualified stock options were forfeited that had previously been issued under the 2021 Equity Incentive Plan.
Share-based compensation costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently settled in non-qualified stock options) totaled $82,457 and $187,615 for the years ended December 31, 2024 and 2023, respectively. Such share-based compensation costs are classified in the Company’s consolidated financial statements in the same manner as if such compensation was paid in cash. The following is a summary of such share-based compensation costs included in the Company’s consolidated statements of operations for the years ended December 31, 2024 and 2023: Schedule of Share-based Compensation Costs
|  | 2024 |  |  | 2023 |
|  | For the Years Ended December 31, |
|  | 2024 |  |  | 2023 |
Share-based compensation expense included in: |  |  |  |  |  |  |  |
Cost of revenue |  | $ | - |  |  | $ | 4,898 |
Advertising and marketing expenses |  |  | - |  |  |  | 1,113 |
Product development costs |  |  | - |  |  |  | 3,570 |
Selling, general and administrative expenses |  |  | 82,457 |  |  |  | 178,033 |
Total share-based compensation expense included in consolidated statement of operations |  | $ | 82,457 |  |  | $ | 187,615 |
As of December 31, 2024, of the 55,556 shares authorized under the 2021 Equity Plan, 23,940 relate to restricted shares issued, 11,104 relate to outstanding non-qualified stock options, 3,401 relate to outstanding incentive stock options, 1,529 related to outstanding restrictive stock units, and 15,581 shares remain available for future equity awards. There was $12,021 in unrecognized compensation expense for unvested restricted stock units at December 31, 2024 which will be recognized over approximately 1 year. As further discussed in Note 14 Subsequent Events below, effective January 2, 2025, the Company issued 9,237 shares of common stock in settlement of restricted stock units issued to three directors that vested immediately. CEA Industries Inc. Notes to Consolidated Financial Statements December 31, 2024 (in US Dollars except share numbers) Restricted Stock Awards No shares of restricted stock were issued during the year ended December 31, 2024 or the year ended December 31, 2023. Stock Options The Company uses the Black-Scholes Model to determine the fair value of options granted. Option-pricing models require the input of highly subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in the subjective input assumptions can materially affect the fair value estimate. The expected stock price volatility assumptions are based on the historical volatility of the Company’s common stock over periods that are similar to the expected terms of grants and other relevant factors. The Company derives the expected term based on an average of the contract term and the vesting period taking into consideration the vesting schedules and future employee behavior with regard to option exercise. The risk-free interest rate is based on U.S. Treasury yields for a maturity approximating the expected term calculated at the date of grant. The Company has never paid any cash dividends on its common stock and the Company has no intention to pay a dividend at this time; therefore, the Company assumes that no dividends will be paid over the expected terms of option awards. The Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different assumptions for options granted throughout the year. No stock options were issued during the year ended December 31, 2024. During the year ended December 31, 2023, the valuation assumptions used to determine the fair value of each option award on the date of grant were: expected stock price volatility 152.23%; expected term of 10 years and risk-free interest rate 3.48%. Employee and Consultant Options A summary of the stock options granted to employees and consultants under the 2017 Equity Plan and the 2021 Equity Incentive Plan during the years ended December 31, 2024 and 2023 are presented in the table below: Schedule of Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value |
Outstanding, December 31, 2022 |  |  | 16,006 |  |  | $ | 107.28 |  |  |  | 7.6 |  |  | $ | - |
Granted |  |  | 11,541 |  |  | $ | 10.80 |  |  |  | 6.9 |  |  | $ | - |
Exercised |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Forfeited |  |  | (1,691 | ) |  | $ | 35.76 |  |  |  | 9.1 |  |  | $ | - |
Expired |  |  | (687 | ) |  | $ | 10.68 |  |  |  | - |  |  | $ | - |
Outstanding, December 31, 2023 |  |  | 25,169 |  |  | $ | 70.44 |  |  |  | 6.6 |  |  | $ | - |
Granted |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Exercised |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Forfeited |  |  | (3,808 | ) |  | $ | 38.77 |  |  |  | - |  |  | $ | - |
Expired |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Outstanding, December 31, 2024 |  |  | 21,361 |  |  | $ | 76.04 |  |  |  | 4.9 |  |  | $ | - |
Exercisable, December 31, 2024 |  |  | 21,361 |  |  | $ | 76.04 |  |  |  | 4.9 |  |  | $ | - |
CEA Industries Inc. Notes to Consolidated Financial Statements December 31, 2024 (in US Dollars except share numbers) A summary of non-vested stock options activity for employees and consultants under the 2017 Equity Plan and the 2021 Equity Plan for the years ended December 31, 2024 and 2023 are presented in the table below: Summary of Non-vested Non-qualified Stock Option Activity
﻿ |  | Number of Options |  |  | Weighted Average Grant-Date Fair Value |  |  | Aggregate Intrinsic Value |  |  | Grant-Date Fair Value |
Nonvested, December 31, 2022 |  |  | 2,396 |  |  | $ | 60.36 |  |  | $ | - |  |  | $ | 144,643 |
Granted |  |  | 11,541 |  |  | $ | 10.56 |  |  | $ | - |  |  | $ | 121,870 |
Vested |  |  | (13,076 | ) |  | $ | 11.04 |  |  | $ | - |  |  | $ | (144,359 | )
Forfeited |  |  | (28 | ) |  | $ | 80.04 |  |  | $ | - |  |  | $ | (2,223 | )
Expired |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Nonvested, December 31, 2023 |  |  | 833 |  |  | $ | 80.04 |  |  | $ | (21,344 | ) |  | $ | 21,800 |
Granted |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Vested |  |  | (417 | ) |  | $ | 26.16 |  |  | $ | 10,672 |  |  | $ | (10,900 | )
Forfeited |  |  | (417 | ) |  | $ | 26.16 |  |  | $ | 10,672 |  |  | $ | (10,900 | )
Expired |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Nonvested, December 31, 2024 |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
For the years ended December 31, 2024 and 2023, the Company recorded $(5,522) and $86,298 as compensation expense related to vested options issued to employees and consultants, net of forfeitures, respectively. As of December 31, 2024, there was no unrecognized share-based compensation related to unvested options. Director Options A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and 2021 Equity Plan during the years ended December 31, 2024 and 2023 are presented in the table below: Schedule of Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value ($000) |
Outstanding, December 31, 2023 |  |  | 4,760 |  |  | $ | 113.34 |  |  |  | 6.0 |  |  | $ | - |
Granted |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Exercised |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Forfeited/Cancelled |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Expired |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Outstanding, December 31, 2023 |  |  | 4,760 |  |  | $ | 113.34 |  |  |  | 5.0 |  |  | $ | - |
Granted |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Exercised |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Forfeited/Cancelled |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Expired |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Outstanding, December 31, 2024 |  |  | 4,760 |  |  | $ | 113.34 |  |  |  | 4.0 |  |  | $ | - |
Exercisable, December 31, 2024 |  |  | 4,760 |  |  | $ | 113.34 |  |  |  | 4.0 |  |  | $ | - |
There was no non-vested non-qualified stock option activity for directors for the years ended December 31, 2023 and December 31, 2024. CEA Industries Inc. Notes to Consolidated Financial Statements December 31, 2024 (in US Dollars except share numbers) Restricted Stock Units A summary of the RSUs awarded to employees, directors and consultants under the 2021 Equity Plan during the years ended December 31, 2024 and 2023 are presented in the table below: Schedule of Restricted Units Activity
|  | Number of Units |  |  | Weighted Average Grant-Date Fair Value |  |  | Aggregate Intrinsic Value |
Outstanding, December 31, 2022 |  |  | 81 |  |  | $ | 89.04 |  |  | $ | - |
Granted |  |  | 9,919 |  |  | $ | 10.08 |  |  | $ | - |
Vested and settled with share issuance |  |  | (10,200 | ) |  | $ | 12.24 |  |  | $ | - |
Forfeited/canceled |  |  | - |  |  | $ | - |  |  | $ | - |
Outstanding, December 31, 2023 |  |  | - |  |  | $ | 8.18 |  |  | $ | - |
Granted |  |  | 14,422 |  |  | $ | 6.93 |  |  | $ | 17,104 |
Vested and settled with share issuance |  |  | (12,893 | ) |  | $ | 6.79 |  |  | $ | (17,189 | )
Forfeited/canceled |  |  | - |  |  | $ | - |  |  | $ | - |
Outstanding, December 31, 2024 |  |  | 1,529 |  |  | $ | 8.18 |  |  | $ | - |
For the years ended December 31, 2024 and 2023, the Company recorded $87,980 and $101,316 as compensation expense related to vested RSUs issued to employees, directors and consultants. As of December 31, 2024, there was $12,021 in unrecognized share-based compensation related to unvested RSUs. As further discussed in Note 14 Subsequent Events below, effective January 2, 2025, the Company issued 9,237 shares of common stock in settlement of restricted stock units issued to three directors that vested immediately.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration